![Paul R. McGuirk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul R. McGuirk
Directeur/Membre du Conseil chez GARDINER HEALTHCARE ACQUISITIONS CORP.
Profil
Paul R.
McGuirk is currently the Director, Chief Development Officer & Executive VP at Gardiner Healthcare Acquisitions Corp.
and also holds the position of Chief Development Officer & Executive VP at Gardiner Founder LLC and President at PRM Pharmaceuticals LLC.
Previously, he worked as the Executive Director at Chemical Technologies, Inc. and as the Chief Technology Officer, Director & EVP at Aeromics, Inc. from 2009 to 2020.
Prior to that, he worked at Pfizer Inc. for 27 years as the Manager-Infectious Diseases Medicinal Chemistry.
Postes actifs de Paul R. McGuirk
Sociétés | Poste | Début |
---|---|---|
GARDINER HEALTHCARE ACQUISITIONS CORP. | Directeur/Membre du Conseil | 01/04/2021 |
PRM Pharmaceuticals LLC | President | - |
Gardiner Founder LLC | Corporate Officer/Principal | - |
Anciens postes connus de Paul R. McGuirk
Sociétés | Poste | Fin |
---|---|---|
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Directeur Technique/Scientifique/R&D | 01/11/2020 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/2009 |
Chemical Technologies, Inc.
![]() Chemical Technologies, Inc. Contract DrillingIndustrial Services Part of Newpark Resources, Inc., Chemical Technologies, Inc. provides retail drilling fluids services. The company is based in Warren. Chemical Technologies was acquired by Newpark Resources, Inc. on June 03, 1997 for $5 million. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Chemical Technologies, Inc.
![]() Chemical Technologies, Inc. Contract DrillingIndustrial Services Part of Newpark Resources, Inc., Chemical Technologies, Inc. provides retail drilling fluids services. The company is based in Warren. Chemical Technologies was acquired by Newpark Resources, Inc. on June 03, 1997 for $5 million. | Industrial Services |
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Gardiner Healthcare Acquisitions Corp.
![]() Gardiner Healthcare Acquisitions Corp. Financial ConglomeratesFinance Gardiner Healthcare Acquisitions Corp. is a blank check company, which engages in merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The company was founded on March 25, 2021 and is headquartered in Shaker Heights, OH. | Finance |
Gardiner Founder LLC | |
PRM Pharmaceuticals LLC |